Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Tris Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Tris Pharma

Peter Ciano has been appointed vice president of corporate development, Tris Pharma.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Peter Ciano has been appointed vice president of corporate development, Tris Pharma. Mr. Ciano will lead and manage all of the company’s commercial activities for its brand side of the business.

Previously, Mr. Ciano worked for Tris as a business development consultant. Prior to that, he spent six years at Kos Pharmaceuticals, most recently serving executive director of corporate development and business planning. While at Kos, he played an important role in many business development transactions including a co-promotion with Takeda Pharmaceuticals and leading a cross-functional team charged with identifying para-IV settlement options in defense of Kos’ key brand product.

“As our technology gains wider acceptance for both Rx and OTC branded businesses, we are increasingly faced with the need for intelligent pursuit of the products and opportunities. Peter’s solid analytical approach coupled with his deep understanding of pharmaceutical marketer’s needs and health care provider’s requirement for reimbursement makes him uniquely qualified to guide and lead Tris in this position,” said Ketan Mehta, founder and chief executive officer of Tris Pharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters